Safety, Tolerability and Pharmacokinetics of Lumateperone in Pediatric Patients With Autism Spectrum Disorder
Clinical trial NCT06557902 · COMPLETED
Trial details
- NCT number
- NCT06557902
- Sponsor
- Intra-Cellular Therapies, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-10
- Primary completion
- 2025-11-26
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.